FDA Allows Abortion Pills to Be Dispensed without In-Person Visit

On Dec. 16, 2021, the FDA permanently lifted the in-person requirements for mifepristone, which will be available via telemedicine appointments and the mail. However, telemedicine appointments for abortions were banned in 19 states and six states had bans on mailing the pills in place at the time of the decision.